Skip to main content
Download PDF

The value of the ACEF II score in Chinese patients with elective and non-elective cardiac surgery

BMC Cardiovascular Disorders volume 22, Article number: 513 (2022) Cite this article

Abstract

Objective

To evaluate the value of the ACEF II score in predicting postoperative hospital death and acute kidney injury requiring dialysis (AKI-D) in Chinese patients.

Methods

This retrospective study included adult patients who underwent cardiopulmonary bypass open heart surgery between January 2010 and December 2015 at Guangdong Provincial People’s Hospital. ACEF II was evaluated to predict in-hospital death and AKI-D using the Hosmer–Lemeshow goodness of fit test for calibration and area under the receiver operating characteristic (ROC) curve for discrimination in non-elective and elective cardiac surgery.

Results

A total of 9748 patients were included. Among them, 1080 underwent non-elective surgery, and 8615 underwent elective surgery. Mortality was 1.8% (177/9748). In elective surgery, the area under the ROC (AUC) of the ACEF II score was 0.704 (95% CI: 0.648–0.759), similar to the ACEF score of 0.709 (95% CI: 0.654–0.763). In non-elective surgery, the AUC of the ACEF II score was 0.725 (95% CI: 0.663–0.787), higher than the ACEF score (AUC = 0.625, 95% CI: 0.553–0.697). The incidence of AKI-D was 3.5% (345/9748). The AUC of the ACEF II score was 0.718 (95% CI: 0.687–0.749), higher than the ACEF score (AUC = 0.626, 95% CI: 0.594–0.658).

Conclusion

ACEF and ACEF II have poor discrimination ability in predicting AKI-D in non-elective surgery. The ACEF II and ACEF scores have the same ability to predict in-hospital death in elective cardiac surgery, and the ACEF II score is better in non-elective surgery. The ACEF II score can be used to assess the risk of AKI-D in elective surgery in Chinese adults.

Peer Review reports

Introduction

Ischemic heart disease is a leading cause of death in many developed and developing countries [1]. Many patients require open-heart surgery, but they are at substantial risk of complications, including pulmonary complications (33%), delirium (26%), and arrhythmias (30%) [2,3,4], especially the elderly patients. These complications prolong hospitalization, lead to readmission, and increase healthcare costs [5,6,7,8]. The overall mortality after open-heart surgery is 1-3% [9, 10] and is even higher in patients who develop postoperative acute kidney injury (AKI) [11, 12]. AKI requiring dialysis (AKI-D) is an independent risk factor for death, and the survival of patients with AKI-D after open-heart surgery remains dismal [12].

Multiple attempts at therapeutic interventions failed to demonstrate benefits in improving renal injury or survival. Successful interventions suggested that intervention should be performed early, within 24 to 48 h after AKI. Still, clinical trials of such early interventions are difficult because it is difficult to anticipate AKI [13, 14]. In addition, the use of biomarkers such as estimated glomerular filtration rate (eGFR) leads to a delay in diagnosis.

Risk stratification is used to predict AKI and identify patients at risk of poor outcomes. There are several models predicting AKI after cardiac surgery [15,16,17]. The Cleveland Risk Score [17] was established using 10 variables, but its external validation is limited and has not been validated in China. The European system for cardiac operative risk evaluation (EuroSCORE II) [18], The American Society of Thoracic Surgeons (STS) score [19], and the ACEF score [20] are commonly used to predict AKI and identify patients who are at risk of death after open-heart surgery. The EuroSCORE II [18] was established with 17 variables based on the EuroSCORE. The American Association for Thoracic Surgery established the STS score using 42 risk factors [19]. Still, the EuroSCORE II and STS scores require complicated calculations, variables, and tools. The ACEF score [20] can quickly and easily assess the risk of death within 30 days after surgery using only three variables (age, ejection fraction, and serum creatinine) [21] in patients who underwent elective cardiac surgery; these three factors are independent risk factors of death and postoperative AKI after elective surgery [15,16,17], but not after non-elective surgery [9]. Ranucci et al. [22] established the ACEF II score by adding emergency surgery and anemia to the ACEF score.

The existing models for AKI-D after cardiac surgery have a poor discriminative ability in Chinese patients since they were established based on European and North American populations. The risk factors of the ACEF and ACEF II models for predicting post-surgery mortality are the same factors also predicting AKI.

We hypothesized that ACEF and ACEF II can be used to predict the occurrence and mortality of AKI after cardiac surgery. Chen SW et al. explained that ACEF can be used to predict all stages of AKI. [23] Chang CH et al. demonstrated that ACEF scores exhibited satisfactory predictive ability for all AKI severities [24]. The performance of ACEF II in predicting death and AKI-D in the Chinese population is unclear.

This study aimed to examine the value of the ACEF II score in predicting in-hospital mortality and postoperative AKI-D in Chinese patients who underwent elective and non-elective cardiac surgery. The results could help improve mortality risk prediction in such patients and identify those needing a closer follow-up.

Methods

Patients

This retrospective study included adult patients (> 18 years) who underwent cardiopulmonary bypass open heart surgery between January 2010 and December 2015 at the Department of Cardiac Surgery of Guangdong Provincial People’s Hospital. The patients were identified through the Electronic Health Record System (EHRs). The exclusion criteria were 1) congenital heart disease, 2) end-stage renal disease, 3) heart transplantation, 4) renal replacement therapy, 5) unilateral nephrectomy, or 6) rescue surgery [18] (including cardiopulmonary resuscitation, intraoperative or before anesthesia; only the first surgical episode was considered). This study was approved by the Medical Ethics Committee of Guangdong Provincial People’s Hospital (#GDREC2016194H). The requirement for individual informed consent was waived.

Data collection

The demographic data (age, sex, hypertension, diabetes, CKD, COPD, CCS class, extracardiac arteriopathy, neurological dysfunction, acute endocarditis, myocardial infarction, and previous cardiac surgery), surgery-related data (ejection fraction, cardiopulmonary bypass (CPB) time, types of cardiac surgery, including coronary artery bypass graft, valve surgery, combined coronary artery bypass graft, and valve procedures, and other cardiac surgeries such as ventricular aneurysm repair, pericardiectomy, thoracic aorta surgery, and combined surgery [25]), and laboratory results (serum creatinine, eGFR, hematocrit, etc.) were collected from the EHRs through structured query language [26] as defined in the EuroSCORE II standard [18]. Creatinine datas were extracted available and the maximal creatinine within 7 days postsurgery was used as the basis for AKI evaluation.The ACEF and ACEF II scores were calculated before surgery.

Definition

AKI was defined as an increase in serum creatinine (Scr) > 0.3 mg/dl (26.5 µmol/L) or an increase in Scr > 50% (reaching 1.5 times the baseline), or a decrease in urine output (< 0.5 ml/kg/h) for more than 6 h according to the KDIGO clinical practice guidelines [27]. Elective surgery was defined as the patient undergoing surgery ≥ 24 h after admission. Non-elective surgery was defined as the patient undergoing surgery within 24 h after admission. The ACEF score was defined as age/ejection fraction + 1 (serum creatinine ≥ 2.0 mg/ dL). The ACEF II score was defined as age/ejection fraction + 1 (serum creatinine > 2.0 mg/dL) + 3 (emergency surgery) + 0.2 × (36%-hematocrit).Dialysis was defined as the appearance of indications that included uremia (eGFR < 10 ml/min, creatinine > 707 µmol/L), hyperkalemia (serum potassium > 5.5 mmol/L), acidosis (decreased plasma [HCO−], or increased plasma [H2CO3] concentration, or pH showed a decreasing trend), volume overload (renal insufficiency accompanied by obvious edema, pulmonary edema, and cardiac insufficiency) [28], or biochemical abnormalities (such as endogenous creatinine clearance rate < 10 mL/min, urea nitrogen > 28.6 mmol/L, or blood creatinine > 707 μmol/L), due to renal insufficiency and were based on clinical judgment by the nephrologist,cardiac surgeon and ICU consultant.and they also participated in dialysis strategy.

Outcome

The primary outcome is AKI-D 7 days postsurgery and the secondary outcome is death during hospitalization.AKI-D includes patients who need dialysis and actually received dialysis due to renal insufficiency.

Statistical analysis

The data were analyzed using SPSS 25.0 (IBM, Armonk, NY, USA) and R (version 3.6.1; https://www.r-project.org). The Kolmogorov–Smirnov test was used to assess the continuous variables for normal distribution. The continuous variables with a normal distribution (or non-normal distribution) were described as means ± standard deviation (or medians [range]), and the differences between groups were analyzed using the analysis of variance (or the rank-sum test). The categorical variables were described as n (%) and analyzed using the chi-square test. The multiple imputations by chained equations were used to deal with the missing data of variables, including hematocrit (0.08%), ejection fraction (4.87%), and cardiopulmonary bypass time (0.42%) [29, 30]. The ability to predict death and AKI-D was validated by discriminability and fit in the general population, patients with elective cardiac surgery, or non-elective cardiac surgery. Discriminability was determined by the area under the receiver operating characteristics (ROC) curve (AUC) (> 0.7). The comparison of AUCs between the scores was determined by the rank-sum test described by DeLong et al. [31]. A calibration curve was drawn based on the predicted and actual values and evaluated by the Hosmer–Lemeshow test. P-values < 0.05 were considered statistically significant.

Results

Characteristics of the patients

This study examined 12,100 patients for eligibility; 2352 were excluded according to the exclusion criteria, and 9748 patients were included (Fig. 1). Among them, 1080 patients underwent non-elective surgery within 24 h after admission, and the remaining 8615 patients underwent elective surgery. The in-hospital mortality was 1.8% (177/9748). The incidence of AKI-D was 3.5% (345/9748). The in-hospital mortality was 1.2% (105/8615) in the elective patients and 6.6% (72/1080) in the non-elective patients. The incidence of AKI-D was 2.6% (227/8615) and 10.9% (118 /1080) in elective and non-elective patients, respectively. The ACEF and ACEF II scores of the patients in the elective surgery group were 0.86 ± 0.30 and 1.01 ± 0.52 and were 0.89 ± 0.37 and 2.08 ± 1.60 in the non-elective surgery group. The patients’ demographic and clinical characteristics are shown in Table 1. The patients with non-elective surgery had a higher proportion of hypertension, hematocrit < 36%, and preoperative critical condition (P < 0.05).

Fig. 1
figure 1

Flowchart of study population selection

Full size image
Table 1 Characteristics of the patients
Full size table

Prediction of the risk of in-hospital death

The AUCs of the ACEF and ACEF II scores for predicting death for all cardiac surgery patients were 0.675 (95%CI: 0.631–0.719) and 0.755 (95%CI: 0.714–0.796) (Fig. 2). The ACEF and ACEF II scores were 0.709 (95%CI 0.654–0.763) and 0.704 (95%CI 0.648–0.759) in elective cases, and 0.625 (95%CI 0.553–0.697) and 0.725 (95%CI 0.663–0.787) in non-elective cases. The calibration curves indicated that ACEF and ACEF II had goodness of fit in predicting death in elective surgery, and ACEF II had goodness of fit in predicting death in non-elective cases (Fig. 3), as evaluated by the Hosmer–Lemeshow test (P > 0.05).

Fig. 2
figure 2

Comparison of the area under the receiver operating characteristic curves (AUROCs) among models for mortality. a Elective cardiac surgery. ACEF score AUROC: 0.709 (95%CI 0.654–0.763) vs. ACEF II score: 0.704 (95%CI 0.648–0.759), P = 0.788. b Non-elective cardiac surgery. ACEF score AUROC: 0.625 (95%CI 0.553–0.697) vs. ACEF II score: 0.725 (95%CI 0.663–0.787), P = 0.020

Full size image
Fig. 3
figure 3

Calibration curves of the ACEF and ACEF II scores for predicting the risk of mortality. a, b Elective cardiac surgery. c, d Non-elective cardiac surgery

Full size image

Anticipating the risk of AKI-D

The AUCs predicting AKI-D were 0.626 (95% CI 0.594–0.658) and 0.718 (95% CI 0.687–0.749) (Fig. 4). The scores were 0.678 (95% CI 0.641–0.715) and 0.711 (95% CI 0.675–0.747) in elective cases, and 0.524 (95% CI 0.467–0.582) and 0.642 (95% CI 0.583–0.702) in non-elective cases. The calibration curves showed that the ACEF II score had goodness of fit in AKI-D after elective surgery, as evaluated by The Hosmer–Lemeshow test (P > 0.05) (Fig. 5).

Fig. 4
figure 4

Comparison of the area under the receiver operating characteristic curves (AUCs) among models for acute kidney injury requiring renal replacement therapy. a Elective cardiac surgery. ACEF score AUC: 0.678 (95%CI 0.641–0.715) vs. ACEF II score AUC: 0.711 (95%CI 0.675–0.747), P = 0.043. b Non-elective cardiac surgery. ACEF score AUC: 0.524 (95%CI 0.467–0.582) vs. ACEF II score AUC: 0.642 (95%CI 0.583–0.702), P < 0.001

Full size image
Fig. 5
figure 5

Calibration curves of ACEF score and ACEF II score for predicting the risk of RRT, respectively. a, b Elective cardiac surgery. c, d Non-elective cardiac surgery

Full size image

Discussion

Risk assessment before cardiac surgery might improve prognosis. Mortality after cardiac surgery has declined in recent decades [10], but AKI-D remains a risk factor for postoperative mortality. Still, the morbidity of AKI-D has not decreased significantly [32, 33] due to the increasing proportion of elderly patients with more comorbidities and complications [34]. The risk factors included in the ACEF and ACEF II models for predicting post-surgery mortality are also risk factors of AKI, and the ACEF can be used to predict postoperative AKI.

Chen SW et al. [23]explained that ACEF can be used to predict all stages of AKI. Chang CH et al. [24] demonstrated that ACEF scores exhibited satisfactory predictive ability for all AKI severities.

Nevertheless, the existing AKI-D models after cardiac surgery have a poor discriminative ability in Chinese with different disease spectrums, mainly because there were established based on European and North American populations. In addition, ACEF is mainly aimed at the elective surgery population and is not suitable for emergency patients. The ACEF II model was developed to adapt the ACEF to emergency surgery, but the performance of ACEF II in predicting death and AKI-D in the Chinese population is unclear. Hence, this study aimed to evaluate the value of the ACEF II score in predicting postoperative hospital death and AKI-D. The results indicate that ACEF and ACEF II have poor discriminative ability in predicting AKI-D in non-elective surgery. ACEF II and ACEF scores have the same ability to predict in-hospital death in elective cardiac surgery, and the ACEF II score is better in non-elective surgery. The ACEF II score can be used to assess the risk of AKI-D in elective surgery.

Several models can predict AKI-D after cardiac surgery [15,16,17]. The Cleveland Risk Score [17] includes 10 variables and is based on the data of 15,838 patients who underwent cardiac surgery, including 68.9% with coronary bypass surgery without valve surgery, which is a procedure increasingly used in China, ranging from 55.1% to 70% [35, 36]. Still, external verification showed poor performance for valve surgery patients [35, 37], and there is no model to evaluate AKI-D for Chinese patients. The EuroSCORE II [18], STS score [19], and ACEF score [20] are commonly used in clinical practice to identify patients at risk of AKI and/or death after open-heart surgery. Still, they have disadvantages. Indeed, the EuroSCORE II [18] includes 17 variables and was established based on 22,381 patients from multiple centers. The STS score [19] includes 42 risk factors based on various heart surgery strategies. Hence, the EuroSCORE II and STS scores require assessing large numbers of factors and variables and complicated calculations, making them arduous to use in the routine clinical setting. The much simpler ACEF score [20] includes only three variables (age, ejection fraction, and serum creatinine) [21] and can quickly and easily assess the risk of 30-day death and AKI-D in elective cardiac surgery [15,16,17], but not in non-elective surgery [9]. The ACEF score could predict severe AKI after coronary artery bypass grafting [23]. Therefore, Ranucci et al. [22] established the ACEF II score by adding emergency surgery and anemia to the ACEF score.

Still, the ACEF and ACEF II scores were not assessed in Chinese patients undergoing elective or non-elective surgery. In the present study, the ACEF II and ACEF scores were calculated to predict in-hospital death in the elective cardiac surgery group. The ACEF II score was better than the ACEF score in the non-elective surgery group. In addition, the ACEF II score can be used to predict the risk of AKI-D in patients with elective cardiac surgery. Still, it should be used with caution in patients with non-elective cardiac surgery. The results showed that the ACEF score could predict the risk of death in patients undergoing elective cardiac surgery. Still, the discrimination of the ACEF score is low in the non-elective surgery group (the area under the ROC curve was < 0.7), which is similar to the results of previous studies [9, 21]. It is probably because the ACEF score was originally established based on the clinical data of a non-elective cardiac surgery population. Indeed, patients with non-elective surgery have a higher proportion of preoperative critical conditions and complicated surgery because of various comorbidities. Non-elective surgery is also an independent risk factor for death after cardiac surgery. The ACEF II and ACEF scores have three common variables with the same weights. The results show that the ability of the ACEF II score to assess death was similar to the ACEF score in the elective surgery population. The ACEF II score includes two supplementary variables (emergency surgery and hematocrit < 36%), which are independent risk factors for death after cardiac surgery [18, 38], as also observed in the present study (Supplementary Table S1). The ACEF II score has also been developed to predict death in patients with non-elective surgery. Although non-elective surgery accounts for a low proportion, their condition is complicated and fatal if not treated in time.

The incidence of AKI-D was 3.5%, higher than the average incidence in the previous studies [37, 39], which might be related to the following reasons. The distribution of medical resources in China is still uneven, and the early diagnosis rate is lower than in Europe and North America. In addition, basic heart surgery is mainly for valvular disease in China [35]. Studies have confirmed that complicated cardiac surgery and cardiopulmonary bypass (CPB) time are independent risk factors for AKI-D [15, 40]. The proportion of complicated heart surgery in Chinese is higher than that of coronary artery disease in Europe and North America (24.6 vs. 19%), and the CPB time was longer than in Europe and North America (123 ± 65.42 vs. 100 ± 36 min) [15]. Finally, the timing to start dialysis treatment is affected by the subjective factors of the consulting physicians, which also affects the incidence.

The variables of the ACEF II score are independent risk factors for AKI-D after cardiac surgery [15,16,17, 41]. Therefore, the results showed that the ability of the ACEF II score to assess AKI-D after non-elective cardiac surgery is acceptable, but not after elective cardiac surgery. The variables of the scoring model are simple, and the condition of non-elective surgery is more complicated. The occurrence of AKI-D might be related to the preoperative critical status, neurological dysfunction, and hypertension, which are independent risk factors for AKI-D after cardiac surgery [39]. It is necessary to establish a scoring system predicting AKI-D suitable for the non-elective cardiac surgery Chinese population.

There are some limitations to this study. First, the retrospective data from a single center inevitably result in some bias, limiting the generalizability of the results. In addition, the mortality was in-hospital death, which might be underestimated due to Chinese customs. Finally, because the calculation of the EuroSCORE II and STS scores requires many variables and complex calculations, those scores could not be calculated because of missing data in most patients. Therefore, only the ACEF could be used as a comparator.

Conclusion

The ACEF II score can be used to distinguish between the low- and high-risk groups of postoperative deaths in patients undergoing elective and non-elective cardiac surgery and provides a clinical score to predict AKI-D in elective cardiac surgery. ACEF and ACEF II have poor discrimination ability in predicting AKI-D in non-elective surgery. ACEF II and ACEF scores have the same ability to predict in-hospital death in elective cardiac surgery, and the ACEF II score is better in non-elective surgery. In addition, the variables of the ACEF II score are easy to obtain, and the score is simple to calculate. Therefore, it can be used in the clinic to optimize the choice of treatment plans and facilitate the allocation of medical resources to Chinese patients.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Collaborators GBDCoD. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(100):1151–210.

    Google Scholar 

  2. Hulzebos EH, Van Meeteren NL, De Bie RA, Dagnelie PC, Helders PJ. Prediction of postoperative pulmonary complications on the basis of preoperative risk factors in patients who had undergone coronary artery bypass graft surgery. Phys Ther. 2003;83(1):8–16.

    Article  PubMed  Google Scholar 

  3. Kassie GM, Nguyen TA, Kalisch Ellett LM, Pratt NL, Roughead EE. Preoperative medication use and postoperative delirium: a systematic review. BMC Geriatr. 2017;17(1):298.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Weymann A, Popov AF, Sabashnikov A, et al. Baseline and postoperative levels of C-reactive protein and interleukins as inflammatory predictors of atrial fibrillation following cardiac surgery: a systematic review and meta-analysis. Kardiol Pol. 2018;76(2):440–51.

    Article  PubMed  Google Scholar 

  5. Koster S, Hensens AG, Schuurmans MJ, van der Palen J. Consequences of delirium after cardiac operations. Ann Thorac Surg. 2012;93(3):705–11.

    Article  PubMed  Google Scholar 

  6. Iribarne A, Chang H, Alexander JH, et al. Readmissions after cardiac surgery: experience of the National Institutes of Health/Canadian Institutes of Health research cardiothoracic surgical trials network. Ann Thorac Surg. 2014;98(4):1274–80.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Villareal RP, Hariharan R, Liu BC, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004;43(5):742–8.

    Article  PubMed  Google Scholar 

  8. Hashemzadeh K, Dehdilani M, Dehdilani M. Postoperative Atrial Fibrillation following Open Cardiac Surgery: Predisposing Factors and Complications. J Cardiovasc Thorac Res. 2013;5(3):101–7.

    PubMed  PubMed Central  Google Scholar 

  9. Barili F, Pacini D, Rosato F, et al. In-hospital mortality risk assessment in elective and non-elective cardiac surgery: a comparison between EuroSCORE II and age, creatinine, ejection fraction score. Eur J Cardiothorac Surg. 2014;46(1):44–8.

    Article  PubMed  Google Scholar 

  10. Saxena A, Dhurandhar V, Bannon PG, Newcomb AE. The Benefits and Pitfalls of the Use of Risk Stratification Tools in Cardiac Surgery. Heart Lung Circ. 2016;25(4):314–8.

    Article  PubMed  Google Scholar 

  11. Olivero JJ, Olivero JJ, Nguyen PT, Kagan A. Acute kidney injury after cardiovascular surgery: an overview. Methodist Debakey Cardiovasc J. 2012;8(3):31–6.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Serraino GF, Provenzano M, Jiritano F, et al. Risk factors for acute kidney injury and mortality in high risk patients undergoing cardiac surgery. PLoS One. 2021;16(5):e0252209.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Star RA. Treatment of acute renal failure. Kidney Int. 1998;54(6):1817–31.

    Article  CAS  PubMed  Google Scholar 

  14. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol. 2003;14(8):2199–210.

    Article  PubMed  Google Scholar 

  15. Wijeysundera DN, Karkouti K, Dupuis JY, et al. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA. 2007;297(16):1801–9.

    Article  CAS  PubMed  Google Scholar 

  16. Mehta RH, Grab JD, O’Brien SM, et al. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation. 2006;114(21):2208–16 quiz.

    Article  PubMed  Google Scholar 

  17. Thakar CV, Arrigain S, Worley S, Yared JP, Paganini EP. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005;16(1):162–8.

    Article  PubMed  Google Scholar 

  18. Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41(4):734–44 discussion 44-5.

    Article  PubMed  Google Scholar 

  19. Jin R, Furnary AP, Fine SC, Blackstone EH, Grunkemeier GL. Using Society of Thoracic Surgeons risk models for risk-adjusting cardiac surgery results. Ann Thorac Surg. 2010;89(3):677–82.

    Article  PubMed  Google Scholar 

  20. Ranucci M, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation. 2009;119(24):3053–61.

    Article  PubMed  Google Scholar 

  21. Ranucci M, Castelvecchio S, Conte M, et al. The easier, the better: age, creatinine, ejection fraction score for operative mortality risk stratification in a series of 29,659 patients undergoing elective cardiac surgery. J Thorac Cardiovasc Surg. 2011;142(3):581–6.

    Article  PubMed  Google Scholar 

  22. Ranucci M, Pistuddi V, Scolletta S, de Vincentiis C, Menicanti L. The ACEF II Risk Score for cardiac surgery: updated but still parsimonious. Eur Heart J. 2018;39(23):2183–9.

    Article  PubMed  Google Scholar 

  23. Chen SW, Chang CH, Fan PC, et al. Comparison of contemporary preoperative risk models at predicting acute kidney injury after isolated coronary artery bypass grafting: a retrospective cohort study. BMJ Open. 2016;6(6):e010176.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Chang CH, Lee CC, Chen SW, et al. Predicting acute kidney injury following mitral valve repair. Int J Med Sci. 2016;13(1):19–24.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Singh N, Gimpel D, Parkinson G, et al. Assessment of the EuroSCORE II in a New Zealand Tertiary Centre. Heart Lung Circ. 2019;28(11):1670–6.

    Article  PubMed  Google Scholar 

  26. Corey KM, Kashyap S, Lorenzi E, et al. Development and validation of machine learning models to identify high-risk surgical patients using automatically curated electronic health record data (Pythia): a retrospective, single-site study. PLoS Med. 2018;15(11):e1002701.

    Article  PubMed  PubMed Central  Google Scholar 

  27. 2012 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Acute Kidney Injury (AKI). Kidney Intl Suppl. 2012;2(4):1-138.

  28. Gibney N, Hoste E, Burdmann EA, et al. Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions. Clin J Am Soc Nephrol. 2008;3(3):876–80.

    Article  PubMed  Google Scholar 

  29. Janssen KJ, Donders AR, Harrell FE Jr, et al. Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol. 2010;63(7):721–7.

    Article  PubMed  Google Scholar 

  30. Marshall A, Altman DG, Holder RL, Royston P. Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol. 2009;9:57.

    Article  PubMed  PubMed Central  Google Scholar 

  31. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–45.

    Article  CAS  PubMed  Google Scholar 

  32. Bove T, Calabro MG, Landoni G, et al. The incidence and risk of acute renal failure after cardiac surgery. J Cardiothorac Vasc Anesth. 2004;18(4):442–5.

    Article  PubMed  Google Scholar 

  33. Drosos G, Ampatzidou F, Sarafidis P, et al. Serum Creatinine and chronic kidney disease-epidemiology estimated glomerular filtration rate: independent predictors of renal replacement therapy following cardiac surgery. Am J Nephrol. 2018;48(2):108–17.

    Article  CAS  PubMed  Google Scholar 

  34. Nicolini F, Agostinelli A, Vezzani A, et al. The evolution of cardiovascular surgery in elderly patient: a review of current options and outcomes. Biomed Res Int. 2014;2014:736298.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Jiang W, Xu J, Shen B, et al. Validation of Four Prediction Scores for Cardiac Surgery-Associated Acute Kidney Injury in Chinese Patients. Braz J Cardiovasc Surg. 2017;32(6):481–6.

    PubMed  PubMed Central  Google Scholar 

  36. Wang X, Lin X, Xie B, et al. Early serum cystatin C-enhanced risk prediction for acute kidney injury post cardiac surgery: a prospective, observational, cohort study. Biomarkers. 2020;25(1):20–6.

    Article  PubMed  Google Scholar 

  37. Hu J, Chen R, Liu S, et al. Global incidence and outcomes of adult patients with acute kidney injury after cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2016;30(1):82–9.

    Article  PubMed  Google Scholar 

  38. Head SJ, Osnabrugge RL, Howell NJ, et al. A systematic review of risk prediction in adult cardiac surgery: considerations for future model development. Eur J Cardiothorac Surg. 2013;43(5):e121–9.

    Article  PubMed  Google Scholar 

  39. O’Neal JB, Shaw AD, Billings FTt. Acute kidney injury following cardiac surgery: current understanding and future directions. Crit Care. 2016;20(1):187.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Axtell AL, Fiedler AG, Melnitchouk S, et al. Correlation of cardiopulmonary bypass duration with acute renal failure after cardiac surgery. J Thorac Cardiovasc Surg. 2019;S0022-5223(19):30286–7.

    Google Scholar 

  41. Karkouti K, Wijeysundera DN, Yau TM, et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation. 2009;119(4):495–502.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful for the contribution of the research personnel from The Medi-Wisdom Information Technology Limited-Liability Company in maintaining the database and contributing to the initial validation of this database.

Funding

This project was supported by grants from the Science and Technology Project of Guangzhou City (201604020037).

Author information

Author notes

  1. Zhiming Mo and Penghua Hu contributed to the work equally and should be regarded as co-first authors.

Authors and Affiliations

  1. The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China

    Zhiming Mo, Yuanhan Chen & Xinling Liang

  2. Department of Nephrology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

    Zhiming Mo, Zhiyong Xie, Yanhua Wu, Zhilian Li, Lei Fu, Yuanhan Chen, Xinling Liang, Huaban Liang & Wei Dong

  3. Division of Nephrology, The Affiliated Yixing Hospital of Jiangsu University, Yixing, China

    Penghua Hu

Authors
  1. Zhiming Mo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Penghua Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhiyong Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yanhua Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhilian Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lei Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yuanhan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xinling Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Huaban Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Wei Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Zhiming Mo carried out the studies, participated in collecting data, and drafted the manuscript. Penghua Hu performed the statistical analysis and participated in its design. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Xinling Liang.

Ethics declarations

Ethics approval and consent to participate

This work has been carried out in accordance with the Declaration of Helsinki (2000) All methods were performed in accordance with the relevant guidelines and regulations. This study was approved by the Medical Ethics Committee of Guangdong Provincial People's Hospital (#GDREC2016194H). The requirement for individual informed consent was waived.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Supplementary Table 1.

Logistic regression analysis of preoperative variables for mortality in all cardiac surgery.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mo, Z., Hu, P., Xie, Z. et al. The value of the ACEF II score in Chinese patients with elective and non-elective cardiac surgery. BMC Cardiovasc Disord 22, 513 (2022). https://doi.org/10.1186/s12872-022-02946-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12872-022-02946-6

Keywords

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us